相关实验视频

Updated: Jul 12, 2025

Treatment Protocol for Rotator Cuff Calcific Tendinitis Using a Single-Crystal Piezoelectric Focused Shock Wave Source

Treatment Protocol for Rotator Cuff Calcific Tendinitis Using a Single-Crystal Piezoelectric Focused Shock Wave Source

Published on: December 23, 2022

对PXE的新治疗方法:针对子宫外化的系统和局部驱动因素

Ida Joely Jacobs^1,2,3, Qiaoli Li^2,3

¹Biomedical Sciences MS Program, Jefferson College of Life Sciences, Thomas Jefferson University, Philadelphia, PA 19107, USA.

International journal of molecular sciences

|October 28, 2023

概括

使用埃维德罗纳酸 (ETD) 和米诺环素 (Mino) 的联合治疗有效地减少了Pseudoxanthoma elasticum (PXE) 的小鼠模型中的子宫外化. 这种方法针对酸盐缺乏和DDR/PARP信号,为这种难以治疗的疾病提供了希望.

科学领域:

遗传学和分子生物学
生物化学生化学
医学研究医学研究

背景情况:

伪松弹性 (PXE) 是一种遗传性疾病,由于ABCC6载体缺乏,导致子宫外化.
降低的血无机酸盐 (PPi) 和激活的DDR/PARP信号传递有助于PXE的病原性.
目前对PXE的治疗方法有限,这凸显了对新型治疗策略的需求.

研究的目的:

调查PPi模拟物埃迪德罗纳特 (ETD) 和DDR/PARP抑制剂米诺环素 (Mino) 在PXE小鼠模型中减少子宫外化的疗效.
评估ETD和Mino对ABCC6小鼠化的联合治疗效果.
探索组合疗法的潜在作用机制.

主要方法:

利用PXE的Abcc6小鼠模型,在化开始之前,在4周大时开始治疗.
在18周的时间内服用埃迪酸 (ETD),米诺环素 (Mino) 或两者的组合.
通过微计算机断层扫描,组织病理学和含量量定量评估子宫外化.

主要成果:

与单个治疗相比,联合ETD和Mino治疗显著降低了Abcc6小鼠的子宫外化.
组合疗法与血清性酸酶活性降低有关.
血PPi度保持不变,这表明PPi恢复之外的机制.

结论:

与埃迪德罗纳酸和米诺环素的联合治疗证明了对Pseudoxanthoma elasticum的有前途的治疗策略.
这种方法有效地针对涉及到PXE的多种病理途径.
需要进一步的研究来将这些发现转化为PXE患者的临床应用.

关键词:

宫外化是一种非宫外化.酸的研究无机铁酸盐是一种无机铁酸盐.米诺环素是什么意思?伪Xanthoma 弹性 (Elasticum) 是一个假象.

更多相关视频

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

相关概念视频

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...